← Emerson Electric Co. (EMR)

narrative.md

Published

# Emerson Electric Co. (NYSE: EMR) — Narrative, FY2026 Q3

Emerson's fiscal year ends September 30. This narrative covers the fiscal year ended
September 30, 2025 and the third quarter of fiscal 2026, the quarter ended June 30, 2026.

Sources: Annual Report on Form 10-K for the fiscal year ended September 30, 2025
(accession 0000032604-25-000087); Quarterly Report on Form 10-Q for the quarter ended
June 30, 2026 (accession 0000032604-26-000043); and Current Reports on Form 8-K dated
August 4, 2026 (accession 0000032604-26-000042), May 5, 2026 (accession
0000032604-26-000034), February 13, 2026 (accession 0000032604-26-000022), February 6,
2026 (accession 0000032604-26-000017), November 20, 2025 (accession
0000032604-25-000094) and November 14, 2025 (accession 0000032604-25-000091).

---

## Business

Emerson is a global automation company. It sells the instruments, valves, control systems
and industrial software that process, hybrid and discrete manufacturers use to run their
plants — measuring pressure, temperature, flow and composition; regulating the movement of
liquids and gases; executing control logic; and optimizing production with modeling and
simulation software. Its customers are chemical, power and renewables, energy, life
sciences, metals and mining, food and beverage, pulp and paper, automotive, medical,
packaging and semiconductor producers, plus the professional trades served by its tools
business. Revenue is overwhelmingly product- and software-license based, sold largely
through a direct sales force, supplemented by independent representatives and, to a lesser
extent, distributors buying for resale. In fiscal 2025 the company sold $18.0 billion,
split by destination into the Americas at 51 percent, Asia, Middle East & Africa at 30
percent (China, 10 percent) and Europe at 19 percent; international sales including U.S.
exports were 59 percent of the total. Emerson had approximately 71,000 employees and
roughly 120 manufacturing locations at September 30, 2025 — about 35 in the United States
and 85 outside it, primarily in Europe and Asia. It was incorporated in Missouri in 1890
and is headquartered in St. Louis.

**How it is organized today.** On November 20, 2025 Emerson announced that, with its
portfolio transformation complete, it had revised its management organization and updated
its reportable segments. Effective in fiscal 2026 the company reports **five segments in
three groupings**, and prior-period amounts have been reclassified to match. The former
Discrete Automation segment was dissolved and its pieces distributed across three of the
surviving segments. (The FY2025 10-K still describes the prior six-segment, two-group
structure; the descriptions below follow the current one, from the November 20, 2025 8-K
and Note 15 of the Q3 FY2026 10-Q, with product and brand detail drawn from the 10-K.)

**Software & Systems group**

- *Control Systems & Software* — automation systems, intelligent software and industrial
  AI. Distributed control systems, safety instrumented systems, SCADA, application
  software, digital twins, asset performance management and cybersecurity, sold mainly to
  process and hybrid manufacturers. Brands include DeltaV and Ovation control systems and
  AspenTech's asset optimization software, which lets industrial manufacturers design,
  operate and maintain their operations for maximum performance. The segment now also
  includes programmable automation controllers moved over from the former Discrete
  Automation segment.
- *Test & Measurement* — the former National Instruments business, now carrying the NI
  brand: software-connected automated test and measurement systems, modular
  instrumentation, data acquisition and control solutions and general-purpose development
  software, used to bring products to market faster and at lower cost.

**Intelligent Devices group**

- *Sensors* (formerly described as Measurement & Analytical) — intelligent instrumentation
  measuring pressure, temperature, level, flow, acoustics, corrosion, pH, conductivity,
  water quality, toxic gases and flame, feeding data to control systems and automation
  software. Brands include Rosemount, Micro Motion and Flexim.
- *Final Control* — control, isolation, shutoff, pressure relief and pressure safety
  valves, digital valve controllers, actuators and regulators. Brands include Fisher, ASCO,
  Bettis, Anderson Greenwood, Crosby, Keystone, KTM and Vanessa. The segment now also
  includes the fluid & motion control business from the former Discrete Automation segment
  — solenoid and pneumatic valves, valve position indicators, cylinders, air preparation
  equipment and electric linear motion.

**Safety & Productivity**

- Tools and connected equipment for mechanical, electrical and plumbing professionals:
  pipe wrenches and cutters, threading and roll-grooving equipment, battery hydraulic press
  and crimping tools, drain cleaners, sewer inspection cameras and locating equipment,
  conduit benders, cable pulling equipment, water jetters and vacuums. Brands include
  RIDGID, Greenlee, Klauke and ProTeam. Recently expanded to include the electrical
  equipment and materials joining businesses from the former Discrete Automation segment.

**How the portfolio got here.** Emerson describes portfolio management as integral to its
growth and value creation strategy, and the past three years reshaped the company into a
narrower, higher-growth, higher-margin automation franchise:

- **AspenTech buy-in** — on March 12, 2025 Emerson completed the purchase of the AspenTech
  common stock it did not already own for approximately $7.2 billion, making AspenTech a
  wholly owned subsidiary reporting into Control Systems & Software. Emerson incurred fees
  of $76 million ($65 million after tax) and paid $76 million to settle AspenTech
  share-based awards; AspenTech separately incurred $127 million ($113 million after tax)
  of deal-related fees. AspenTech's results, formerly a separate segment, are now
  consolidated into Control Systems & Software for all periods presented.
- **National Instruments** — acquired October 11, 2023 at an equity value of $8.2 billion;
  NI had revenues of approximately $1.7 billion and pretax earnings of approximately
  $170 million for the twelve months ended September 30, 2023. It is now Test &
  Measurement.
- **Open Grid Systems Limited** — acquired by AspenTech on November 15, 2024 for a total
  purchase price of $46 million net of cash; a network model management technology provider.
- **Flexim and Afag** — acquired in 2023 for $715 million net of cash.
- **Climate Technologies / Copeland** — on May 31, 2023 Emerson sold a majority stake in
  Climate Technologies to private equity funds managed by Blackstone in a $14.0 billion
  transaction, recognizing a pretax gain of approximately $10.6 billion (approximately
  $8.4 billion after tax) and retaining a 40 percent non-controlling interest in the
  standalone business, Copeland. In August 2024 it sold that 40 percent interest to
  Blackstone funds for $1.5 billion and the related note receivable to Copeland for
  $1.9 billion.
- **InSinkErator** — divested to Whirlpool Corporation on October 31, 2022 for $3.0 billion,
  producing a pretax gain of approximately $2.8 billion (approximately $2.1 billion after
  tax).
- **Metran** — Emerson's Russia-based manufacturing subsidiary, divested March 31, 2023;
  a pretax loss of $47 million was recognized on the exit of Russian operations, which had
  historically represented approximately 2.0 percent of consolidated annual sales.

**Other business characteristics.** Spending on R&D, engineering expense and
customer-funded engineering and development was 8.1 percent of sales in both fiscal 2025
and fiscal 2024, up from 6.9 percent in 2023. Estimated consolidated order backlog was
$8.6 billion at September 30, 2025 against $8.4 billion a year earlier (Intelligent Devices
$4,499 million; Software and Control $4,130 million, on the then-current segment
structure), with approximately 75 percent expected to convert to revenue within twelve
months. Principal raw materials are steel, cast iron, electronics, rare earth metals,
aluminum and brass, with plastics and petroleum-based chemicals to a lesser extent; Emerson
seeks multiple sources for each to avoid dependence on any one supplier. Management does
not regard any segment as dependent on a single patent, trademark or license. Emerson
maintains a cybersecurity risk management program overseen by the Audit Committee and the
Board, run by a Chief Information Security Officer who briefs the Audit Committee
quarterly; the company states that to date no cybersecurity threat or incident has
materially affected its business, strategy, results or financial condition.

*(Business section from the FY2025 10-K, accession 0000032604-25-000087, with the current
segment structure from the November 20, 2025 8-K, accession 0000032604-25-000094, and Note
15 of the Q3 FY2026 10-Q, accession 0000032604-26-000043.)*

---

## Risk factors

Condensed from Item 1A of the FY2025 10-K (accession 0000032604-25-000087). Emerson groups
its risks into business and operational, industry and general economic, and legal and
regulatory.

**Business and operational**

- *Competition.* Markets are highly competitive and potentially volatile; Emerson competes
  on product performance, quality, service and price. Some competitors have substantially
  greater sales, assets and financial resources. Competitive pressure could hit prices,
  demand, margins or market share. Certain businesses also depend on independent sales
  representatives and distributors, and the sale, financial instability or defection of one
  of those channel partners could weaken Emerson's position.
- *Product development and technological change.* Businesses are affected by varying
  degrees of technological change — artificial intelligence and machine learning among them
  — producing unpredictable product transitions, shortened life cycles and a premium on
  being first to market. Emerson may fail to recoup R&D investment. It also flags the risk
  of not positioning for adoption of battery storage, industrial hydrogen, mobility and
  power generation, enhanced grid demand management, carbon capture and sequestration, or
  advanced nuclear power.
- *Intellectual property.* Patents, trademarks, copyrights and trade secrets may be
  challenged, infringed, invalidated or circumvented, or misappropriated through
  unauthorized system access, employee theft or industrial espionage.
- *Acquisitions and divestitures.* Deals require favorable environments and domestic and
  foreign regulatory approvals. As a result of the AspenTech, NI and Climate Technologies
  transactions Emerson explicitly notes it now has **a narrower business focused on
  higher-growth markets, and may encounter more volatility and be more vulnerable to
  changing market conditions.** Integration, separation and the timing and degree of
  anticipated benefits are all uncertain.
- *Raw materials.* Shortages or price increases in steel, cast iron, electronics, rare
  earth metals, aluminum, brass, plastics and petroleum-based chemicals could raise
  operating costs and hurt competitive position; hedging may not fully mitigate.
- *Global production footprint.* A majority of manufacturing facilities are outside the
  United States and emerging-market sales represent over one-third of total sales.
  Facilities are exposed to weather and natural disaster (including climate change
  effects), labor strife, war (Russia-Ukraine and other global conflicts), political
  unrest, terrorism, epidemics, nationalization and host-country legal and political
  upheaval.
- *Capital markets access.* Investing, acquiring and refinancing maturing debt all require
  access to capital markets and bank credit lines for short-term borrowings; volatility
  raises the cost of commercial paper and other debt or could close off access entirely.
  Customers, suppliers or financial institutions losing that access would also hurt Emerson.
- *Key personnel.* Success depends in part on the skills, experience and industry knowledge
  of management and key employees.
- *Security and data privacy.* IT networks are exposed to failures, outages, terrorism,
  natural disaster, employee error or malfeasance, server and cloud-provider breaches, and
  cyberattacks ranging to advanced persistent threats. Emerson expects cyberattack risk to
  increase as AI capabilities improve and are used both to find vulnerabilities and to
  build attacks, with additional exposure from its own and its vendors' AI use. Breaches
  could mean theft of trade secrets, disclosure of confidential data, litigation, penalties
  under privacy laws and reputational damage; compliance with privacy and data-localization
  regimes increases operational complexity.
- *Product failure.* Products and services incorporate complex, leading-edge hardware and
  software integrated into process, hybrid and discrete manufacturing environments, so the
  impact of a catastrophic product failure could be significant. Cybersecurity incidents
  aimed at embedded software could generate third-party damage claims, a risk enhanced by
  the increasingly connected nature of the products.
- *Artificial intelligence.* AI use raises accuracy, IP infringement, data privacy and
  cybersecurity risks; competitors may adopt AI faster or better; and the regulatory
  landscape is rapidly evolving with potentially prohibitive requirements.

**Industry and general economic**

- *Trade policy, tariffs and currency.* Emerson sells, manufactures, engineers and
  purchases globally across mature and emerging markets. Changes in trade terms,
  restrictions, tariffs, taxes, protection measures and retaliatory countermeasures could
  hurt results. The 10-K states directly that recent changes in U.S. trade policy — the
  application or increase of tariffs and subsequent retaliatory measures — have created a
  dynamic environment and that there is no assurance Emerson can mitigate the full impact
  on its costs, demand, supply chain or the global economy. Currency swings have affected
  operating results and hedging may not offset them.
- *Recession and end-market downturns.* Operations have historically been exposed to
  significant volatility from general economic conditions and end-market downturns, which
  could depress sales, trigger goodwill or long-lived asset impairment charges, and force
  more extensive and costlier restructuring — workforce reductions, facility
  consolidations, centralization — whose benefits may be delayed or never realized.

**Legal and regulatory**

- *Tax.* Emerson is taxed in the U.S. and numerous non-U.S. jurisdictions. Its effective
  rate, cash flows and results can move with the geographic mix of earnings, local law
  changes and the multiple overlapping regimes implementing the OECD global minimum tax.
  Returns are regularly audited and disputes could adjust tax liabilities.
- *Improper conduct.* Exposure to the U.S. Foreign Corrupt Practices Act, the U.K. Bribery
  Act and similar laws, with operations in many parts of the world that have experienced
  government corruption; internal controls may not always prevent improper conduct by
  employees, agents or business partners.
- *Litigation and environmental.* Emerson is party to proceedings involving intellectual
  property, commercial transactions, government contracts, the integration of emerging
  technologies including AI, M&A, employment, benefit plans, antitrust, anti-corruption,
  accounting, import and export, health and safety, product liability including asbestos,
  and environmental matters. It could incur substantial cleanup or damage costs under
  environmental laws, and notes a continuing lack of consistent climate-change legislation
  and standards. Sustainability goals depend on technologies not yet commercially available
  and on the efforts of suppliers and others; failing or being perceived to fail to meet
  them could bring reputational damage, enforcement actions and private litigation.

**Related contingency disclosure.** Emerson engages an outside expert for an actuarial
estimate of expected costs to resolve all pending and future asbestos claims including
defense costs, plus related insurance receivables; the asbestos reserve is recorded
undiscounted and is based on projected claims through 2065. At September 30, 2025 there
were no known contingent liabilities management believed would be material to the financial
statements, nor any material commitments outside the normal course of business. At June 30,
2026 the balance sheet carried $119 million of asbestos litigation liability in Other
liabilities and $50 million of asbestos-related insurance receivables in Other assets.

---

## MD&A — fiscal year ended September 30, 2025

From Item 7 of the FY2025 10-K (accession 0000032604-25-000087). Dollars in millions except
per-share amounts unless noted.

**Top line.** Net sales were $18.0 billion, up $0.5 billion or 3 percent. Underlying sales
— excluding currency translation, acquisitions and divestitures — were also up 3 percent,
on 2.5 percent higher price and 0.5 percent higher volume. Underlying sales rose 5 percent
in the U.S. and 1 percent internationally. International destination sales including U.S.
exports rose 1 percent to $10.6 billion, with U.S. exports of $1.4 billion up 5 percent;
underlying, Asia, Middle East & Africa was up 3 percent (China down 4 percent) and Canada
up 7 percent, while Europe fell 2 percent and Latin America was flat. Origin sales by
international subsidiaries totaled $9.4 billion, up 1 percent.

**Margins and costs.** Cost of sales fell $110 to $8,497. Gross profit was $9,519 against
$8,885, and gross margin rose 2.0 percentage points to 52.8 percent — the prior year had
carried $231 of acquisition-related inventory step-up amortization worth roughly 1.3
points of margin, and favorable price less net material inflation added to the gain. SG&A
of $5,103 was down $39, falling 1.1 points to 28.3 percent of sales on cost-reduction
savings concentrated at Test & Measurement and AspenTech. Other deductions, net of $1,245
were down $189: intangibles amortization fell $193 (the prior year included $136 of
backlog amortization tied to Test & Measurement) and restructuring fell $92, partly offset
by $118 higher acquisition/divestiture fees and related costs. Interest expense, net was
$237 against $175 in 2024 and $34 in 2023, the increase reflecting higher debt to support
the AspenTech transaction.

**Earnings.** Pretax earnings from continuing operations of $2,934 rose $914, or 45
percent, with Intelligent Devices up $146 and Software and Control up $545. Income taxes
were $696 at a 24 percent effective rate, against 21 percent in 2024 and 22 percent in
2023; discrete tax items of $36 ($0.06 per share) and non-deductible AspenTech fees added
roughly 2 points. Net earnings from continuing operations attributable to common
stockholders were $2,285, up 41 percent from $1,618, and diluted EPS from continuing
operations was $4.03, up 43 percent from $2.82. The prior year had absorbed NI purchase
accounting, higher associated restructuring, and a pretax loss of $279 ($217 after tax,
$0.38 per share) on the agreement to sell the Copeland note receivable for $1.9 billion.
Adjusted diluted EPS from continuing operations was $6.00 against $5.49. Discontinued
operations contributed $8 ($0.01 per share) versus $350 ($0.61) in 2024, so net earnings
attributable to common stockholders were $2,293 ($4.04 per share) against $1,968 ($3.43).

**Segments, on the then-current structure.** Intelligent Devices sales were $12.4 billion,
up $239 or 2 percent, with underlying up 2 percent on price; Final Control rose $176 (4
percent) on strength in power end markets, Measurement & Analytical rose $82 (2 percent) on
mixed geographies and difficult comparisons, Discrete Automation rose $15 (1 percent), and
Safety & Productivity fell $34 (2 percent) on softness in all geographies. Intelligent
Devices earnings were $2,953, up $146 or 5 percent, with margin up 0.7 points to 23.8
percent and adjusted EBITA margin up 0.5 points to 25.9 percent. Software and Control sales
were $5.7 billion, up $292 or 5 percent, underlying up 5 percent on 2.5 percent higher
volume and 2.5 percent higher price; Control Systems & Software rose $270 (7 percent) on
strong AspenTech growth, including a favorable contract-renewal timing effect, and demand
in process and power, while Test & Measurement rose $22 (2 percent). Software and Control
earnings were $827, up $545 or 193 percent, with margin up 9.3 points to 14.5 percent and
adjusted EBITA margin up 4.0 points to 31.0 percent.

**Cash and capital structure.** Operating cash flow from continuing operations was $3.7
billion, up $359 or 11 percent on higher earnings and favorable working capital changes;
free cash flow from continuing operations was $3,245, up 12 percent. Including discontinued
operations, total operating cash flow was $3,098, held back by roughly $0.6 billion of
income taxes paid on the Copeland equity sale — the same payment that pushed operating
working capital to 11.3 percent of sales from 8.0 percent. Net cash paid for acquisitions
was $37, against $8,342 in 2024. Total debt rose to $13,116 from $7,687, with commercial
paper borrowings at approximately $4.2 billion at year end; in March 2025 Emerson issued
€500 of 3.0% notes due 2031, $500 of 5.0% notes due 2035 and €500 of 3.5% notes due 2037.
Management acknowledged leverage and debt ratios elevated versus historical levels while
expecting to retain investment-grade ratings and to improve the ratios through disciplined
capital allocation. Dividends were $1,192 ($2.11 per share) and share repurchases $1,167
(9.3 million shares at an average $125.66). Total assets were $42 billion and stockholders'
equity $20 billion. A $3 billion 364-day backup facility entered February 11, 2025 sat
alongside a $3.5 billion revolver from February 2023, with no borrowings ever drawn under
either.

**Retirement plans.** At September 30, 2025 U.S. pension plans were overfunded by $856 in
total, roughly 29 percent in excess of the projected benefit obligation, while non-U.S.
plans were underfunded by $65. Effective January 1, 2025 Emerson implemented a new profit
sharing retirement program for U.S. non-union employees, funded by surplus pension assets,
and froze future service accruals in the principal U.S. defined benefit plan after
December 31, 2024.

---

## Current quarter — third quarter of fiscal 2026 (quarter ended June 30, 2026)

From the Q3 FY2026 10-Q (accession 0000032604-26-000043) and the third-quarter results
press release furnished as Exhibit 99.1 to the 8-K dated August 4, 2026 (accession
0000032604-26-000042). Dollars in millions except per-share amounts unless noted.

**The quarter.** Net sales were $4,873, up 7 percent from $4,553. Underlying sales were up
6 percent on 3 percent higher volume and 3 percent higher price, with currency translation
adding 1 point. Underlying orders — a trailing three-month average excluding currency,
significant M&A and AspenTech — were up 7 percent. Underlying sales rose 10 percent in the
U.S. and 4 percent internationally: the Americas up 8 percent, Asia, Middle East & Africa
up 8 percent (China down 3 percent) and Europe down 1 percent. Chief Executive Lal
Karsanbhai described demand as robust, led by Software & Systems and broad-based growth in
North America and Asia, while noting that the conflict in the Middle East remains fluid.

**Tariff refunds.** In February 2026 the U.S. Supreme Court ruled that the International
Emergency Economic Powers Act does not authorize the imposition of tariffs, and on
April 20, 2026 U.S. Customs and Border Protection opened an administrative portal for
refund claims. During the quarter Emerson filed claims and received tariff refunds of $82
($0.11 per share), recorded in cost of sales. The timing and amount of any further refunds
remain uncertain and no benefit was recognized at June 30, 2026 for additional potential
refunds of previously paid IEEPA tariffs. This single item is the principal driver of the
quarter's gross-margin expansion and is excluded from adjusted EPS.

**Margins and earnings.** Cost of sales was $2,218, up $58, and gross margin of 54.5
percent rose 1.9 points, primarily on the tariff refunds. SG&A of $1,343 rose $77 but fell
0.2 points to 27.6 percent of sales on operating leverage and cost-reduction savings. Other
deductions, net were $311, up $13, as restructuring costs rose (to $87 from $37) against
lower intangibles amortization ($204 from $219). Interest expense, net was $85, down from
$95. Pretax earnings from continuing operations were $916, up $182 or 25 percent, at an
18.8 percent margin, 270 basis points better than the prior year. Income taxes were $198 at
a 22 percent effective rate versus $154 and 21 percent, with the One Big Beautiful Bill Act
adding about 1 point through a lower foreign-derived intangible income deduction following
the change to domestic research and development treatment in fiscal 2026; Emerson expects
the OBBBA to slightly benefit the rate from fiscal 2027. Earnings from continuing
operations attributable to common stockholders were $718, up 24 percent, and diluted EPS
from continuing operations was $1.28 against $1.03; including the year-ago quarter's
discontinued operations, total diluted EPS was $1.28 against $1.04. Adjusted diluted EPS
was $1.71 against $1.52, up 13 percent. Adjusted total segment EBITA was $1,387 at a 28.5
percent margin, up 140 basis points from $1,232 and 27.1 percent.

**Segments (current five-segment structure).**

- *Software & Systems* — sales $1,644, up $164 or 11 percent, underlying up 11 percent on 7
  percent higher volume and 4 percent higher price. Control Systems & Software sales were
  $1,199, up 7 percent on strong demand in power; Test & Measurement was $445, up 23
  percent on semiconductor and aerospace & defense strength. Underlying sales rose 13
  percent in the Americas and 16 percent in Asia, Middle East & Africa (China up 14
  percent) while Europe fell 1 percent. Earnings were $296, up 21 percent, with margin up
  1.4 points to 18.0 percent on leverage, lower intangibles amortization and cost-reduction
  savings; adjusted EBITA margin was 31.8 percent, down 0.3 points. Test & Measurement
  swung to a $11 segment profit from a $26 loss.
- *Intelligent Devices* — sales $2,677, up $142 or 6 percent, underlying up 5 percent on 3
  percent higher price and 2 percent higher volume. Sensors rose $78 (8 percent) on
  Americas strength in power and LNG; Final Control rose $64 (4 percent) on Asia, Middle
  East & Africa and Americas growth, again led by power. Earnings rose $55, or 9 percent,
  with margin up 0.8 points to 24.3 percent on leverage and favorable price less net
  material inflation, partly offset by unfavorable mix from increased greenfield project
  activity and higher restructuring. Adjusted EBITA margin was 27.9 percent, up 2.4 points.
- *Safety & Productivity* — sales $552, up $14 or 3 percent, underlying up 2 percent on 4
  percent higher price against 2 percent lower volume. The Americas rose 4 percent and
  Asia, Middle East & Africa 1 percent while Europe fell 6 percent. Earnings fell $10, or
  10 percent, with margin down 2.3 points to 16.9 percent on higher restructuring and
  deleverage on lower volume; adjusted EBITA margin rose 0.8 points to 21.2 percent.

**Nine months.** Net sales were $13,781, up 5 percent, with underlying up 3 percent on 3
percent higher price while volume took an approximately 1.5 percent hit from the timing of
software renewals and the conflict in the Middle East; currency added 2 points. Gross
margin of 53.6 percent rose 0.4 points on favorable price less net material inflation and
the $82 of tariff refunds, partly offset by software-renewal timing. SG&A of $3,902 was
28.3 percent of sales, down 0.4 points. Other deductions, net fell $200 to $744, driven by
a $175 decline in acquisition/divestiture fees tied to the prior-year AspenTech transaction
and the absence of $65 of AspenTech backlog amortization. Interest expense, net rose $113
to $258 on higher short-term borrowings and long-term debt used to fund AspenTech in March
2025. Pretax earnings of $2,484 were up $346. The effective tax rate fell to 22 percent
from 25 percent — favorable tax items worth about 2 points, and the absence of $49 ($0.09
per share) of prior-year AspenTech discrete taxes and non-deductible fees worth about 3
points, against the roughly 1-point OBBBA drag. Earnings from continuing operations
attributable to common stockholders were $1,941, up 18 percent, with diluted EPS of $3.45
against $2.91 and adjusted diluted EPS of $4.71 against $4.38. By segment for the nine
months: Software & Systems sales $4,600 (up 7 percent) and earnings $762 (up $109, or 17
percent, margin up 1.4 points, adjusted EBITA margin 30.8 percent, down 0.9 points
including roughly 2 points of software-renewal timing drag); Intelligent Devices sales
$7,580 (up 4 percent) and earnings up $71 with margin flat and adjusted EBITA margin up 0.9
points; Safety & Productivity sales $1,601 (up 3 percent) with earnings down $7.

**Cash and balance sheet.** Operating cash flow was $1,425 in the quarter, up 34 percent,
and free cash flow $1,323, up 36 percent. For the nine months, operating cash flow from
continuing operations was $2,902, up $238, and free cash flow $2,618 after $284 of capital
expenditures, up $217. Total cash provided by operating activities was $2,902 against
$2,088, the improvement reflecting $585 of income taxes paid in the second quarter of
fiscal 2025 on the Copeland equity sale that did not recur. Cash used in investing was
$322; cash used in financing was $1,920, comprising $898 of share repurchases and $935 of
dividends. In the first quarter Emerson repaid €500 of 1.25% euro notes that matured in
October 2025. At June 30, 2026 total assets were $42,208, cash $2,180, inventories $2,513,
goodwill $18,122, other intangible assets $8,686, short-term borrowings and current
maturities $5,587, long-term debt $7,526 and common stockholders' equity $20,379. Operating
working capital of $2,290 was up $251 from September 30, 2025 on higher inventory; the
current ratio was 0.9, total debt-to-total capital 39.2 percent, net debt-to-net capital
34.9 percent, and the interest coverage ratio 8.2X for the trailing twelve months against
9.6X a year earlier, the decline reflecting higher interest expense. Remaining performance
obligations — Emerson's backlog measure in the quarterly report — were approximately $9.6
billion, with roughly 75 percent expected to convert within twelve months. Emerson expects
fiscal 2026 restructuring expense and related costs of approximately $185.

**Capital returns.** Emerson repurchased 2,543 thousand shares during the quarter at an
average $139.21. In November 2025 the Board authorized the purchase of up to 50 million
shares, on top of the March 2020 authorization for 60 million; approximately 63.2 million
shares remained available at June 30, 2026. Also in November 2025 the Board raised the
quarterly dividend to an annualized rate of $2.22 per share. In January 2026 the company's
2025 Employee Stock Purchase Plan commenced, permitting eligible employees to buy
discounted stock through payroll deductions, with a maximum of 10 million shares issuable
over the plan's term.

**Fiscal 2026 outlook, raised.** Alongside the third-quarter results Emerson raised its
full-year guidance. Consolidated net sales are expected up approximately 5 percent, with
underlying sales up approximately 3.5 percent excluding a 1.5 percent favorable currency
impact. Diluted EPS is expected at approximately $4.89 and adjusted EPS at approximately
$6.55, the bridge comprising roughly $1.39 of intangibles amortization, $0.24 of
restructuring and related costs, $0.09 of acquisition/divestiture fees, $0.05 of discrete
taxes and $(0.11) of IEEPA tariff refunds. Operating cash flow is expected at approximately
$4.1 billion and free cash flow at approximately $3.6 billion after roughly $0.45 billion
of capital spending. The outlook assumes returning approximately $2.2 billion to
shareholders — about $1.0 billion of repurchases and about $1.2 billion of dividends. For
the fourth quarter specifically, guidance calls for net sales growth of approximately 5
percent, underlying growth of approximately 5 percent, EPS of approximately $1.45 and
adjusted EPS of approximately $1.85. For comparison, the outlook issued with the FY2025
10-K in November 2025 called for sales up approximately 5.5 percent, underlying up
approximately 4 percent, EPS of $4.73 to $4.93, adjusted EPS of $6.35 to $6.55, operating
cash flow of $4.0 to $4.1 billion and free cash flow of $3.5 to $3.6 billion.

**Other developments during fiscal 2026.** On February 10, 2026 Emerson entered a $2
billion, 364-day revolving backup credit facility with JPMorgan Chase Bank, N.A. as agent,
expiring February 9, 2027, replacing the $3 billion 364-day facility from February 11, 2025
that expired by its terms; it sits alongside the existing $3.5 billion five-year revolver
from February 2023. Neither facility has ever been drawn, and there are no outstanding
loans or letters of credit under the new one (8-K dated February 13, 2026, accession
0000032604-26-000022). At the annual meeting held February 3, 2026, shareholders elected
three directors, approved executive compensation on an advisory basis and ratified KPMG LLP
as auditor for fiscal 2026; a proposal to amend the Restated Articles of Incorporation to
declassify the Board received 415,208,804 votes for against 5,746,906 opposed but failed
because it required 85 percent of outstanding shares (8-K dated February 6, 2026, accession
0000032604-26-000017). On November 13, 2025 the Compensation Committee granted Special
Performance-based Awards to President and CEO Lal Karsanbhai and Executive Vice President
and Chief Operating Officer Ram Krishnan — 350,000 stock options each, in five tranches of
70,000 at exercise prices of $128.46 (the grant-date close), $160.575, $192.69, $224.805
and $256.92 per share, representing premiums of 25, 50, 75 and 100 percent; each tranche
vests pro rata over five years and must be exercised within ten years (8-K dated
November 14, 2025, accession 0000032604-25-000091). There has been no significant change in
Emerson's market risk exposure during the three and nine months ended June 30, 2026, and
management concluded disclosure controls and procedures were effective with no material
change in internal control over financial reporting during the quarter.

---

## Subsequent events

The Q3 FY2026 10-Q (accession 0000032604-26-000043) contains no subsequent-events note; its
fifteen notes run from basis of presentation through business segments without one, and
Part II of that report raises no post-period matter. No acquisition, divestiture,
financing, borrowing or litigation outcome is disclosed as occurring after June 30, 2026 in
that filing.

The material post-period items Emerson has disclosed are:

- **Quarterly dividend declared, August 4, 2026.** Emerson declared a quarterly cash
  dividend of $0.555 per share of common stock, payable September 10, 2026 to stockholders
  of record on August 14, 2026 (8-K dated August 4, 2026, accession 0000032604-26-000042,
  Exhibit 99.1). This is consistent with the annualized $2.22 per share rate the Board set
  in November 2025.
- **Fiscal 2026 outlook raised, August 4, 2026.** Full-year guidance was increased to
  approximately 5 percent net sales growth, approximately $4.89 of EPS and approximately
  $6.55 of adjusted EPS, with operating cash flow of approximately $4.1 billion and free
  cash flow of approximately $3.6 billion (same 8-K and exhibit). The detail is set out in
  the current-quarter section above.
- **Board addition effective August 3, 2026.** Jennifer G. Newstead joined Emerson's Board
  of Directors effective August 3, 2026, having been elected by the Board on May 5, 2026,
  and was appointed to the Compensation Committee and the Corporate Governance and
  Nominating Committee as of that date. Ms. Newstead is Senior Vice President and General
  Counsel of Apple and was previously Chief Legal Officer at Meta; the Board determined she
  is independent. She receives an award of restricted stock units representing a $95,000
  pro rata portion of the $190,000 RSU component of the annual non-management director
  retainer (8-K dated May 5, 2026, accession 0000032604-26-000034, Item 5.02).

Emerson's fourth quarter of fiscal 2026 ends September 30, 2026; results for that quarter
and the full fiscal year had not been reported as of the filings covered here.